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Syzygium  aqueum leaf
Extract  standardization
a  b  s  t  r  a  c  t
In this  study,  the  acute  and subchronic  toxicity  effect  of the  Syzygium  aqueum  leaf  extract
(SA)  was  evaluated.  For  the  acute  toxicity  study,  a  single  dose  of 2000  mg/kg  of  the  SA was
given  by oral-gavage  to  male  Sprague-Dawley  (SD)  rats.  The  rats  were  observed  for mortal-
ity and  toxicity  signs  for 14  days.  In  the  subchronic  toxicity  study  the  SA was  administered
orally  at  doses  of 50,  100,  and 200  mg/kg  per  day  for 28 days  to male  SD  rats.  The  animals
were  sacriﬁced  at the  end  of  the  experiment.  The  parameters  measured  including  food  and
water intake,  body  weight,  absolute  and relative  organ  weight,  blood  biochemical  tests  and
histopathology  observation.  In both  the  acute  and subchronic  toxicity  studies,  SA did  not
show any  visible  signs  of  toxicity.  There  were  also  no  signiﬁcant  differences  between  the
control and  SA  treated  rats  in terms  of their  food  and  water  intake,  body  weight,  absoluteSD  rats and  relative  organ  weight,  biochemical  parameters  or gross  and microscopic  appearance
of the  organs.  There  were  no acute  or subchronic  toxicity  observed  and our results  indicate
that  this  extract  could  be  devoid  of any  toxic  risk. This is the  ﬁrst in  vivo  study  reported  the
safety and  toxicity  of  SA.
© 2014  The  Authors.  Published  by Elsevier  Ireland  Ltd.  This  is  an  open  access  article  under
Y-NC-Nthe CC  B
1. Introduction
Syzygium aqueum (Eugenia aquea) is a medicinal plant,
widely found in tropical regions such as Malaysia and
Indonesia. Rumphius, the author of The Ambonese Herbal:
Volume I has mentioned that S. aqueum was used in the tra-
ditional  medicine of Ambon and the details of its isolated
compound has appeared in NAPRALERTTM [1]. Various
parts of this plant are used in traditional medicine; while
the  leaves has been shown to possess antibiotic activity and
relieving  child birth pains [2]. A decoction of the S. aqueum’s
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astringent bark is used for thrush [3]. In Malaysia, the pow-
dered  dried leaves have been used to treat mouth ulcers and
a  preparation of its roots has been used to relieve itching
and  reduce swelling [4].
Recently, the SA was shown to have antihyperglycemic
properties [5]. The extract and its six bioactive compounds
effectively enhanced adipogenesis, stimulated glucose
uptake, increased adiponectin secretion and as well as
being  non-cytotoxic to 3T3-L1 cells [6]. The leaf extract has
also  been reported to have cosmeceutical properties, anti-
tyrosinase, anticellulite, and lypolitic [7]. Other researchers
have also established the free radical scavenging ability and
high  phenolic content of this plant extract [4,7,8].
Despite the increasing number of reports on the medic-
inal  beneﬁts of the S. aqueum leaf, the in vivo toxicological
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ffect of the plant extract has yet to be reported. It is
herefore deemed necessary to evaluate the acute and sub-
hronic  toxicity of the S. aqueum leaf extract (SA) in a rat
odel.  The toxicity study would serve as a very important
aseline for further studies in developing this plant as an
erbal  medicine.
.  Materials and methods
.1.  Experimental animals
Male  Sprague-Dawley (SD) rats at 6-weeks of age
weighing approximately 160–200 g) were obtained from
he  Animal house, School of Science, Monash University,
andar Sunway, Malaysia. The rats were acclimatized to
he  animal holding facility at the International Medical
niversity (IMU) for 7 days before the start of the exper-
ments. The rats were housed in individual polycarbonate
ages and were given food rat chow (Gold Coin) ad libitum
nd  had free access to distilled water. The rats were main-
ained  at 23 ± 2 ◦C on a light/dark cycle of 12 h. All of the
nimal procedures were subjected to review and approval
y  the Research and Ethics Committee of the IMU  and are
n  compliance with the National Institutes of Health (NIH)
uidelines for humane treatment of laboratory animals.
.2.  Plant collection
The  leaves were obtained from Kuala Lumpur, Malaysia.
t  was harvested and collected from March to June 2012.
he  leaves were authenticated at the Herbarium of the For-
st  Research Institute of Malaysia (FRIM) with the given
ample number PID 210712-15. The leaves were thor-
ughly washed with copious amount of distilled water
o  remove dirt, following that the wet leaves were dried
n  an oven at 37 ◦C for one week. During this time, the
eaves were periodically turned over to provide uniform
rying. The dried leaves were ground to a ﬁne powder
sing a Fritsch dry miller and the total powder obtained
as weighed.
.3.  Extraction of SA
About  1 kg of the powdered leaves was extracted in 96%
thanol  (1:10, w/v). The extraction was carried out at room
emperature and was left for shaking for 24 h in an orbital
haker. The suspension thus obtained was ﬁltered using a
14  Whatman ﬁlter paper and the ﬁltrate collected. Ethanol
ltrate  was concentrated using a rotary evaporator at 40 ◦C.
he  dried crude extract was further concentrated by allow-
ng  it to stand overnight in an oven at 37 ◦C to remove trace
f  ethanol solvent. The dried extract was stored at 4 ◦C and
ts  stability was monitored for 12 months.
.4. Standardization of SA against myricitrinThe SA was standardized against myricitrin [5] on an
gilent 1100UV HPLC system (Agilent, MO,  USA), con-
isting of a quaternary gradient pump (model G1311A)
ith an on-line vacuum degasser (model G1322A), aneports 1 (2014) 718–725 719
automated sample injector (model G1313A), and a 1100-
UV  detector (model G1314A). The SA (10 mg/ml) was
injected (10 L) into the HPLC system with myricitrin
(1 mg/ml) (Sigma Chemical, St. Louis, MO)  used as the
authentic marker. The standardization was  carried out on a
Chromolith  C18 column (2.0 mm × 150 mm,  3 m)  (Merck,
Darmstadt, Germany) with a Chromolith guard column
(2.2  mm × 50 mm,  1 m)  (Merck, Darmstadt, Germany).
The mobile phase consisted of solvent A: 0.1% formic acid
in  water and solvent B: 0.1% formic acid in acetonitrile. A
gradient  elution was  performed at a ﬂow rate of 0.5 ml/min
as  follows: 0–10 min, 10% B; 10–20 min, 70% B; 20–30 min,
100%  B; and ﬁnally 5 min  for washing and reconditioning
the column with 100% B. The UV absorbance was monitored
at  254 nm.  Quantitative estimations were based on the
area  of peaks of sample (SA) and corresponding authentic
marker (myricitrin) to ensure a standardized preparation
of  extract.
2.5. Toxicity evaluation
2.5.1.  Acute toxicity study
The  acute toxicity study was  conducted to determine
the adverse effects of SA feeding on the vital organs
(liver, kidney, heart and pancreas) and the biochemical
parameters (alanine aminotransferase, alkaline phosphate,
creatinine, urea and total protein). This was  carried out
according to the Organisation of Economic Co-operation
and Development (OECD) guideline 420 [9]. Prior to dos-
ing  with the extract, the rats were fasted overnight from
food,  but were allowed free access to water. A single dose of
2000  mg/kg of SA was orally gavaged in 5 male SD rats. The
rats  in the control group (n = 5) were given olive oil as vehi-
cle.  All of the experimental animals were maintained under
close  observation for any signs of toxicity and mortality
immediately after dosing, at 4 h and at 24 h and inter-
vals, and twice daily for 14 days. After overnight fasting,
on  day 15th, the rats were anaesthetized using ketamine
and xylazine (50 mg/kg and 5 mg/kg, respectively) and
blood  samples were collected via cardiac puncture. All
the  animals were sacriﬁced by cervical dislocation. The
vital  organs mainly liver, kidney, heart and pancreas was
removed, cleaned with saline, weighed and preserved in
10%  formalin for further histopathology observation. Rela-
tive  organ weight was calculated as (weight of organ/body
weight of rat on day of sacriﬁce) × 100% [10].
2.5.2. Subchronic toxicity study
The subchronic toxicity study was  evaluated according
to the OECD guideline 407 OECD [11] to determine the
adverse effects of SA feeding for 28 days on the vital organs
(liver,  kidney, heart and pancreas) and the biochemical
parameters (alanine aminotransferase, alkaline phosphate,
creatinine, urea and total protein). Twenty male SD rats
were  divided randomly into four groups (5 rats per group).
The  experimental design was  shown as below:Group 1: Control rats (received olive oil as vehicle)
Group 2: 50 mg/kg (administered with 50 mg/kg of SA)
Group 3: 100 mg/kg (administered with 100 mg/kg of SA)
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 (red lin
tructureFig. 1. Chromatogram of the standardized SA (blue line) against myricitrin
indicates  the peak for myricitrin at retention time 17 min. The chemical s
Group 4: 200 mg/kg (administered with 200 mg/kg of SA)
Toxic manifestations and mortality were monitored
daily for 28 days. At the end of the experiment, all
the rats were anaesthetized using ketamine and xylazine
(50  mg/kg and 5 mg/kg, respectively) and blood samples
were collected via cardiac puncture. Following this, the rats
were  sacriﬁced by cervical dislocation. Their vital organs
liver,  kidney, heart and pancreas were harvested, cleaned
with  saline, weighed and preserved in 10% formalin for
histopathology analyses. Relative organ weight was calcu-
lated  as described earlier.
2.6.  Histopathology observation
Small  blocks of tissues were taken from the organs
harvested from the rats and processed using an auto-
mated tissue processor (Leica TP1020, Hi-tech Sdn. Bhd.,
Malaysia). After processing, the tissues were sectioned to
a  thickness of 5 M using a rotary microtome and dried
overnight in an oven at 37 ◦C. The sections were stained
with hematoxylin and eosin (H&E) and examined micro-
scopically for signs of toxicity.
2.7. Biochemical analysis
Blood  samples collected via cardiac puncture into a
serum separator tube (BD-Vacutainer, BiTA Lifescience,
Malaysia) were left at room temperature for 30 min  to
allow  clotting to take place. Serum was obtained from the
clotted  blood via centrifugation (5000 rpm for 15 min) and
stored  at −80 ◦C prior to analysis. The serum samples were
analyzed for determination of alanine aminotransferase
(ALT), alkaline phosphate (ALP), creatinine, urea and total
protein.e) on an analytical HPLC with detection wavelength at 254 nm.  The arrow
 of myricitrin is depicted in the chromatogram.
2.8.  Statistical analysis
All  data are expressed as mean ± SD. Each value repre-
sents a minimum of ﬁve rats (n = 5) in a group. Data were
analyzed using Student’s paired t-test and one-way ANOVA
(SPSS  version 16). A p < 0.05 was  considered statistically
signiﬁcant.
3. Results
3.1. Extraction and standardization
The  extraction yield of SA was observed to be 10% (100 g
yield  in a total 1 kg powdered leaf extraction). To ensure
the  consistency of the SA preparation, chemical standard-
ization was  carried out using HPLC as described in Section
2.4.  A standardized HPLC proﬁle of the SA against myricitrin
was  established (Fig. 1). We  had previously reported myric-
itrin  to be one of the bioactive compounds found in the
SA  [5]. Hence, myricitrin was used as authentic marker in
preparing  a standardized extract. The amount of myricitrin
in  the SA was quantiﬁed to be 0.1 ± 0.02 mg/g extract.
3.2. Acute and subchronic toxicity evaluation
There were no signs of toxicity or mortality was
observed in both the acute and subchronic toxicity studies.
All  the rats were in healthy condition, maintained normal
behaviors and usual movement patterns until the end of the
experimental period. Postulating that, SA is safe to be used
as  a medicinal plant with no toxic effects and the LD50 of
this  plant was therefore estimated to be above 2000 mg/kg
b.wt.
T. Manaharan et al. / Toxicology Reports 1 (2014) 718–725 721
Table 1
Absolute and relative organ weight of control and SA treated rats at a single dosage of 2000 mg/kg b.wt. in the acute toxicity study for 14 days.
Acute toxicity
Absolute organ weight (g) Relative organ weight (%)
Control SA 2000 mg/kg b.wt. Control SA 2000 mg/kg b.wt.
Liver 7.7 ± 0.5 7.9 ± 0.3 4.0 ± 0.2 4.2 ± 0.4
Kidney 1.2 ± 0.1 1.1 ± 0.2 0.6 ± 0.3 0.5 ± 0.2
Heart 0.5 ± 0.1 0.6 ± 0.2 0.4 ± 0.1 0.5 ± 0.1
Pancreas 0.9 ± 0.2 0.7 ± 0.1 0.8 ± 0.1 0.6 ± 0.3
Data indicate mean ± SD, n = 5. There are no signiﬁcant (p > 0.05) differences between the control and SA treated rats in their absolute and relative organ
weight.
Table 2
Absolute and relative organ weight of control and SA treated rats at doses of 50, 100, and 200 mg/kg b.wt. in the subchronic toxicity study for 28 days.
Subchronic toxicity
Absolute organ weight (g) Relative organ weight (%)
Control SA 50 mg/kg
b.wt.
SA  100 mg/kg
b.wt.
SA  200 mg/kg
b.wt.
Control  SA 50 mg/kg
b.wt.
SA  100 mg/kg
b.wt.
SA  200 mg/kg
b.wt.
Liver 7.3 ± 0.8 8.1 ± 0.2 7.8 ± 0.5 8.0 ± 0.4 3.8 ± 0.2 4.2 ± 0.4 3.9 ± 0.6 4.0 ± 0.5
Kidney 1.1 ± 0.1 1.0 ± 0.2 0.9 ± 0.2 1.2 ± 0.1 0.6 ± 0.1 0.5 ± 0.1 0.5 ± 0.2 0.6 ± 0.3
Heart  0.8 ± 0.1 0.6 ± 0.2 0.8 ± 0.1 0.7 ± 0.3 0.9 ± 0.2 0.5 ± 0.1 0.8 ± 0.2 0.9 ± 0.2
 0.1 1.0 ± 0.2 0.8 ± 0.2 0.9 ± 0.3 1.1 ± 0.1































































Subch ronic toxicity 
Control
SA 50 mg/kg b. wt.
SA 100 mg/kg b. wt.
SA 200 mg/kg b. wt.
Fig. 2. Body weight of control and SA treated rats in the acute toxicityPancreas 0.9 ± 0.3 1.0 ± 0.2 0.8 ± 0.1 0.9 ±
ata indicate mean ± SD, n = 5. There are no signiﬁcant (p > 0.05) differen
eight.
.2.1. Body weight measurement
The  body weight of rats were measured weekly until the
nd  of acute and subchronic toxicity studies. There were no
igniﬁcant  (p > 0.05) differences in the body weight changes
etween the control and SA treated rats (Fig. 2).
.2.2. Food and water consumption
The  amount of food and water consumed was measured
aily from the quantity of food and water supplied and the
mount  remaining after 24 h (Fig. 3). These data showed
o  statistically signiﬁcant (p > 0.05) differences between
ontrol rats and SA treated rats in both the acute and sub-
hronic toxicity studies.
.2.3.  Absolute and relative organ weight
Tables 1 and 2 show the absolute and relative organs
eight of control and SA treated rats from the acute and
ubchronic toxicity studies, respectively. There were no
igniﬁcant (p > 0.05) differences observed in the liver, kid-
ey,  heart and pancreas of control and SA treated rats in
oth  acute and subchronic toxicity studies.
.2.4. Biochemical analysis
Tables  3 and 4 show the results of various biochemi-
al tests performed on the sera of control and SA treated
ats from the acute and subchronic toxicity studies, respec-
ively.  There were no signiﬁcant (p > 0.05) differences in the
utcome  of the biochemical tests analyzed between the
ontrol  and SA treated rats in both acute and subchronic
oxicity evaluation..2.5.  Histopathology observations
Histopathological  examination of the vital organs; liver,
idney,  heart and pancreas of animals treated with SA did
ot  show any differences when compared with control in(for 14 days) and subchronic toxicity (for 28 days) studies. Data indicate
mean ± SD, n = 5. There are no signiﬁcant (p > 0.05) differences between
the control and SA treated rats in their body weight.both the acute toxicity and subchronic toxicity studies. In
the  acute toxicity study, the liver showed normal archi-
tecture, clear lumen of central vein and no evidence of
lesion  (Fig. 4); the kidney showed adequate glomeruli and
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Fig. 3. Consumption of food and water by the control and SA treated rats durin
studies.  Data indicate mean ± SD, n = 5. There are no signiﬁcant (p > 0.05) differenc
Table 3
Results of biochemical tests performed on the serum of control and SA
treated rats at a single dosage of 2000 mg/kg b.wt. in the acute toxicity
study for 14 days.
Acute toxicity
Biochemical parameters Control SA 2000 mg/kg b.wt.
ALT (U/L) 65 ± 2 63 ± 2
ALP  (U/L) 281 ± 2 280 ± 1
Creatinine (mol/L) 58 ± 3 56 ± 2
Urea  (mmol/L) 7 ± 2 6 ± 1
Total  protein (g/L) 57 ± 1 58 ± 2Data indicate mean ± SD, n = 5. There are no signiﬁcant (p > 0.05) dif-
ferences between the control and SA treated rats in their biochemical
parameters tested.normal tubules, with no trace of focal intestinal edema
and lesion (Fig. 4); the heart showed normal architecture
of the myocardium (images not shown); and the pan-
creas showed normal arrangement of acini, with adequate
Table 4
Results of biochemical tests performed on the serum of control and SA treated rat
for  28 days.
Subchronic toxicity
Biochemical parameters Control SA 50 mg/kg b.w
ALT (U/L) 63 ± 1 64  ± 1 
ALP (U/L) 275 ± 2 277 ± 4 
Creatinine (mol/L) 60 ± 3 57 ± 3 
Urea (mmol/L) 8 ± 2 6 ± 1 
Total protein (g/L) 53 ± 1 54 ± 1 
Data indicate mean ± SD, n = 5. There are no signiﬁcant (p > 0.05) differences betweg the acute toxicity (for 14 days) and subchronic toxicity (for 28 days)
es between the control and SA treated rats in their food and water intake.
islets  (images not shown). Similar results were observed
in  the subchronic tocity study where the liver, kidney,
heart and pancreas of animals treated with SA (50, 100,
and  200 mg/kg b.wt.) did not show any differences when
compared with control. The photomicrographs of liver and
kidney  of animals treated with SA (50, 100, and 200 mg/kg
b.wt.)  in subchronic toxicity study was  shown in Fig. 5,
while  the heart and pancreas was  not shown. In conclu-
sion, no lesions or pathological changes attributable to the
administration of SA were found in the organs of rats in
the  experimental groups. Indicating that SA up to a maxi-
mum  concentration of 2000 mg/kg b.wt. is safe to be used
without any adverse toxicological effects.4. Discussion
Natural therapeutic medicine has become universally
popular in primary healthcare, particularly in developing
s at doses of 50, 100, and 200 mg/kg b.wt. in the subchronic toxicity study
t. SA 100 mg/kg b.wt. SA 200 mg/kg b.wt.
62 ± 2 64 ± 2
274 ± 4 276 ± 1
56 ± 1 58 ± 3
8 ± 1 7 ± 2
55 ± 3 56 ± 2
en the control and SA treated rats in their biochemical parameters tested.
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Fig. 4. Photomicrographs from the liver and kidney of control and SA treated rats at a single dosage of 2000 mg/kg b.wt. in the acute toxicity study for












r4  days. The liver showing hepatocytes arranged around central veins w
he  kidney, showing adequate glomeruli and normal tubules, with no evi
elated  microscopic changes in both the liver and kidney of SA treated rat
ountries such as Malaysia. Medicinal plants are pre-
umed to be safe without any compromising health effects
12,13]. Appropriate use of medicinal plants in dietary
upplementation is very important in the maintenance of
ealth  [14]. Many studies have reported the harmful effects
rom  improper use of medicinal plants [15–17]. Therefore,
ig. 5. Photomicrographs from the liver and kidney of control and SA treated rats
or  28 days. The liver showing hepatocytes arranged around central veins with no
he  kidney, showing adequate glomeruli and normal tubules, with no evidence o
elated  microscopic changes in both the liver and kidney of SA treated rats compvidence of necrosis, lesion or any pathological damage (H&E, 20×), and
f glomerular damage or lumen casts, (H&E, 20×). There are no treatment
ared to the control rats.
evaluating the toxicological effects of any medicinal plant
extract  intended to be used in animals or humans is a cru-
cial  part of its assessment for potential toxic effects.
S. aqueum leaf has been used as medicinal plant in trop-
ical  regions and there are an increasing number of studies
reporting on its health beneﬁts [4,5,7]. Recently S. aqueum
 at doses of 50, 100 and 200 mg/kg b.wt. in the subchronic toxicity study
 evidence of necrosis, lesion or any pathological damage (H&E, 20×), and
f glomerular damage or lumen casts, (H&E, 20×). There are no treatment
ared to the control rats.
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leaf extract (SA) and its bioactive compound, myricitrin
have been established as a potent antihyperglycemic agent
[6,8].  Although the SA has been reported to have heavy
metals far below the permissible levels for nutraceutical
use [18], there is a lack of proven scientiﬁc studies on the
toxicity  effect of SA. It is deemed important to evaluate
the toxicity effect of a medicinal plant extract in order to
increase  the conﬁdence in their safety to humans, partic-
ularly  for use in the development of nutraceuticals and
pharmaceuticals. There exist many studies on the acute
and  subchronic toxicity of plant extracts in rat models
[12,19–24]. Therefore, the present study was carried out
to  evaluate the acute and subchronic toxicity effects of SA
using  an in vivo model. To our best knowledge, this is the
ﬁrst  study reported the toxicity effects of SA in SD rats.
In  the acute toxicity study, a maximum dose of
2000 mg/kg b.wt. of the SA caused neither signs of toxicity
nor  mortality during the 14 days of experiment. Through-
out  the 14 day periods all animals were found to be healthy
with  no changes in their skin and fur, eyes and mucous
membranes, and also respiratory, circulatory, autonomic
and central nervous system and as well as somatomotor
activity and behavioral patterns. Therefore, it is safe to
propose that its oral LD50 value should be greater than
2000 mg/kg. Subsequently, the subchronic toxicity study
was  advocated as a fundamental test to assess safety of
SA.  In this 28-day subchronic toxicity evaluation, rats were
given  SA at doses of 50, 100, and 200 mg/kg b.wt. showed
no  mortality or any symptoms of toxicity.
According to Ref. [25], after some exposure to poten-
tially toxic substances, there will be a slight reduction in
body  weight gain. In our acute and subchronic toxicity
studies, all rats at each dosage group continued to gain
weight throughout the experimental periods (Fig. 2). This
suggests  that administration of the SA did not affect the
body  weight of the rats. In addition, no signiﬁcant changes
in  the food and water consumption of the SA treated rats
compared to the control rats in both the acute and sub-
chronic toxicity studies (Fig. 3). Utilization of food and
water  exhibited normal metabolism in the animals [26]
and  this suggests that the administration of the SA did not
retard  the growth of the rats.
We also observed no changes in the absolute weight of
the  liver, kidney, heart and pancreas of the rats in the acute
toxicity  (Table 1) and subchronic toxicity (Table 2) stud-
ies.  This suggests no gross toxic effect from the SA to the
vital  organs. Demma  et al. [27] reported that relative organ
weight  is more indicative of toxicity than absolute organ
weight. Our results revealed, there were also no signiﬁ-
cant  changes in the relative organ weight of rats treated
with SA compared to the control rats in the acute toxic-
ity  (Table 1) and subchronic toxicity (Table 2) studies. The
gross  and microscopic observations conducted in all the
above  mentioned organs further suggested no toxic effect
of  the extract at the concentrations studied.
The liver and kidney are very sensitive organs to toxic
substances and can serve as an important index of the phys-
iological  and pathological status of both the animals and
humans  [10,28]. Therefore, we decided to focus only on
the  liver function test and kidney function test as biochem-
ical  parameters. The alanine aminotransferase (ALT) andeports 1 (2014) 718–725
alkaline  phosphatase (ALP) are enzymes mainly found in
the  liver and kidneys. The total protein; albumin and glob-
ulin  are mainly found in the blood. An increase in blood
ALT,  ALP and total protein levels indicates impaired liver
and  kidney function and chances of developing an infec-
tion  [23]. Creatinine and urea are waste products excreted
in  urine by kidneys. As the kidneys become impaired, the
creatinine and urea levels in the blood will rise due to poor
clearance by the kidneys [14].
In this study, biochemical parameters in particular, ALT,
ALP,  creatinine, urea and total protein were tested and the
analysis  showed there were no signiﬁcant differences in
ALT,  ALP, creatinine, urea and total protein levels of the rats
treated  with SA compared to the control in both the acute
toxicity (Table 3) and subchronic toxicity (Table 4) studies.
Although there is a slight decrease or increase in the level
of  biochemical parameters in SA treated rats compared to
the  control, these values were still within the normal range.
The  biochemical ﬁndings suggested that the administration
of SA did not cause any toxicological effect.
Gross and microscopic examination on the vital organs,
liver, kidney, heart and pancreas as well revealed no
treatment-related changes due to the administration of SA
in  the animals. Only the liver and kidney were explored
more for histopathology observation because of their pri-
mary  function to expel toxins that results from body’s
metabolism of food, water, drug or any other substances
that consumed. In both the acute toxicity (Fig. 4) and sub-
chronic  toxicity (Fig. 5) studies, the rats treated with the
SA  showed; normal architecture of the liver, and adequate
glomeruli and normal tubules in the kidney. There is no
evidence of lesion due to toxic effect of SA in the liver
and kidney. There were also no microscopic changes was
observed in heart and pancreas of the SA treated rats com-
pared  to the control rats (images not shown). In conclusion,
the  acute and subchronic toxicity studies showed that the
SA  did not produce any signs of toxicity. It is safe to be used
as  a medicinal plant. However, further studies to determine
the  long-term toxicity effects of SA on animals are needed
to  establish the safety and toxicity of this plant extract.
Apart from that current toxicology research are focusing on
the  usage of female rats to test the adverse effect of medic-
inal  plant extracts. Female rats are more sensitive to toxic
substances and their pathological changes are can be eas-
ily  revealed [28]. Therefore, further acute and subchronic
toxicity studies on female SD rats are deemed important to
be  carried out to ensure a complete safety proﬁle of SA.
5.  Conclusion
In this study, the SA was established to have a LD50
value greater than 2000 mg/kg. Administration of the SA
(50,  100, and 200 mg/kg b.wt.) to male SD rats for 28 days
did  not result in death or cause adverse effects in any of
the  experimental animals. There were no signiﬁcant dif-
ferences  observed in the absolute or relative weight of
liver,  kidney, heart and pancreas. In addition, there were no
gross  or microscopic abnormalities observed in any of these
organs.  Furthermore, all of the biochemical tests performed
on  the sera of the experimental animals were in the nor-
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oxicity effects were observed. Although the cytotoxicity
f SA was established before, this is the ﬁrst in vivo study
eport that the SA is devoid of any toxic risk. However, fur-
her  long-term toxicity studies using SA may  therefore be
arranted  before this extract can be further developed as
 nutraceutical or pharmaceutical product.
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